Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.
D M Tollefsen, P W Majerus
D M Tollefsen, P W Majerus
Published June 1, 1975
Citation Information: J Clin Invest. 1975;55(6):1259-1268. https://doi.org/10.1172/JCI108045.
View: Text | PDF
Research Article

Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.

  • Text
  • PDF
Abstract

Monovalent goat antibody fragments (Fab) that were monospecific for human fibrinogen were isolated by affinity chromatography on fibrinogen-Sepharose and used as a direct probe for the involvement of fibrinogen in platelet aggregation and the release reaction. The antifibrinogen Fab inhibited aggregation of washed human platelets induced by thrombin (0.1-10 U/ml) by 50-95%, but had no effect on (14-C)-serotinin release and only a slight inhibitory effect on 125-I-thrombin binding to platelets. Inhibition of aggregation was not observed with nonimmune goat Fab or rabbit antihuman albumie bound tightly at saturation to surface fibrinogen molecules. After washing the platelets once to remove unbound Fab, aggregation by subsequently added thrombin was no longer inhibited. The antifibrinogen Fab inhibited the clotting of fibrinogen by thrombin but did not effect the rate of fibrinopeptide A release, indicating that the Fab inhibits clotting by interfering with the polymerization of fibrin monomers. Our experiments suggest that fibrinogen released from platelets is directly involved in thrombin-induced aggregation of washed platelets, perhaps through polymerization of fibrin monomers generated by proteolytic cleavage of released fibrinogen.

Authors

D M Tollefsen, P W Majerus

×

Total citations by year

Year: 1996 1993 1992 1991 1990 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 Total
Citations: 1 1 1 1 1 3 3 3 5 2 6 2 4 5 6 1 2 1 3 51
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (51)

Title and authors Publication Year
Immunocytochemical Aspects of Platelet Membrane Glycoproteins and Adhesive Proteins During Activation
H Suzuki, H Yamazaki, K Tanoue
Progress in Histochemistry and Cytochemistry 1996
Thrombospondin as an agglutinin of platelets
S Satoh, K Takahashi, N Sakuragawa
Thrombosis Research 1993
The mammalian blood platelet: Its role in haemostasis, inflammation and tissue repair
PA Gentry
Journal of Comparative Pathology 1992
Anabolic/androgenic steroid abuse and thrombosis: Is there a connection?
GS Ferenchick
Medical Hypotheses 1991
Vitronectin binds to activated human platelets and plays a role in platelet aggregation
E Asch, E Podack
Journal of Clinical Investigation 1990
Human Fibrinogen
HA Scheraga, JA Shafer, DL Higgins
Critical Reviews in Clinical Laboratory Sciences 1988
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988
Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus
ZR Gan, RJ Gould, JW Jacobs, PA Friedman, MA Polokoff
The Journal of biological chemistry 1988
Current aspects on human platelet activation and responses
VM Steen, H Holmsen
European Journal of Haematology 1987
Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells
WA Frazier
The Journal of Cell Biology 1987
Formation and regulation of platelet and fibrin hemostatic plug
J Hawiger
Human Pathology 1987
Expression of intracellular fibrinogen on the surface of stimulated platelets
G COURTOIS, JJ RYCKEWAERT, VL WOODS, MH GINSBERG, EF PLOW, GA MARGUERIE
European Journal of Biochemistry 1986
Biochemistry of Platelets
GJ Roth
Biochemistry of Platelets 1986
Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes
VM Dixit, NJ Galvin, KM O'Rourke, WA Frazier
The Journal of biological chemistry 1986
Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology
J Soria, C Soria, JY Borg, M Mirshahi, H Piguet, P Tron, C Fessard, JP Caen
British Journal of Haematology 1985
A monoclonal antibody against human thrombospondin inhibits platelet aggregation
VM Dixit, DM Haverstick, KM O'Rourke, SW Hennessy, GA Grant, SA Santoro, WA Frazier
Proceedings of the National Academy of Sciences 1985
In vitro study of the inhibition of coagulation induced by different radiocontrast molecules
J Belleville, J Baguet, J Paul, G Clendinnen, R Eloy
Thrombosis Research 1985
Epidemiological characteristics of platelet aggregability
TW Meade, MV Vickers, SG Thompson, Y Stirling, AP Haines, GJ Miller
BMJ : British Medical Journal 1985
Platelet Membrane Glycoproteins
JN George, AT Nurden, DR Phillips
1985
Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons
ME Wheeler, AC Cox, RC Carroll
Journal of Clinical Investigation 1984
Redistribution of the fibrinogen receptor of human platelets after surface activation
JC Loftus, RM Albrecht
The Journal of Cell Biology 1984
Monoclonal Antibodies against Platelet Membrane Glycoproteins. Characterization and Effect on Platelet Function
JL McGREGOR, J BROCHIER, F WILD, G FOLLEA, MC TRZECIAK, E JAMES, M DECHAVANNE, L McGREGOR, KJ CLEMETSON
European Journal of Biochemistry 1983
FIBRINOGEN INTERACTION WITH PLATELET RECEPTORS?
S Niewiarowski, E Kornecki, AZ Budzynski, TA Morinelli, GP Tuszynski
Annals of the New York Academy of Sciences 1983
CALCIUM REGULATION OF GLYCOPROTEINS IIb AND IIIa IN HUMAN PLATELET MEMBRANES
DR Phillips, K Fujimura, LK Jennings, L Parise, L Fitzgerald, JE Fox
Annals of the New York Academy of Sciences 1983
An improved method for washing of human platelets with prostacyclin
M Radomski, S Moncada
Thrombosis Research 1983
Fibrinogen interaction with human platelets: Effect of other coagulation factors, prostaglandins and platelet inhibitors
H Al-Mondhiry, JO Ballard, V McGarvey
Thrombosis Research 1983
Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations
DR Phillips, AK Baughan
The Journal of biological chemistry 1983
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets
T Fujimoto, S Ohara, J Hawiger
Journal of Clinical Investigation 1982
Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets
ZM Ruggeri, R Bader, L Marco
Proceedings of the National Academy of Sciences 1982
Relationship between Fibrinogen Binding and the Platelet Glycoprotein Deficiencies in Glanzmann's Thrombasthenia Type I and Type II
H Lee, AT Nurden, A Thomaidis, JP Caen
British Journal of Haematology 1981
In vitro Methods and the Study of Platelet Mechanisms
MA Packham, JF Mustard
Vox Sanguinis 1981
Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata
J Lahav, RO Hynes
Journal of Supramolecular Structure and Cellular Biochemistry 1981
Fibrinogen is the receptor for the endogenous lectin of human platelets
TK Gartner, JM Gerrard, JG White, DC Williams
Nature 1981
Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets
J Hawiger, S Parkinson, S Timmons
Nature 1980
Effect of fibrinogen on ADP-induced platelet aggregation
M Tomikawa, M Iwamoto, S Söderman, B Blombäck
Thrombosis Research 1980
Interaction of lentil lectin with human platelets. Evidence against glycoprotein II as aggregation mediator
P Ganguly, NG Fossett
Biochemical and Biophysical Research Communications 1980
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel
1980
Bacterial Adherence
EH Beachey
1980
Exposure of platelet fibrinogen receptors by ADP and epinephrine
JS Bennett, G Vilaire
Journal of Clinical Investigation 1979
Inhibition of collagen-induced platelet aggregation by antibodies to distinct types of collagens
L Balleisen, H Nowack, S Gay, R Timpl
Biochemical Journal 1979
Content and release of β-thromboglobulin and platelet factor 4 in patients with qualitative platelet defects
FI Pareti, J Dawes, F Franchi, PM Mannucci, DS Pepper
Thrombosis Research 1979
The ability of fibrinogen fragments to support ADP-induced platelet aggregation
JC Holt, M Mahmoud, PJ Gaffney
Thrombosis Research 1979
Thrombin induced surface changes of human platelets
K Subbarao, VV Kakkar
Biochemical and Biophysical Research Communications 1979
Human platelets possess an inducible and saturable receptor specific for fibrinogen
GA Marguerie, EF Plow, TS Edgington
The Journal of biological chemistry 1979
Platelet responses in health and disease
MI Barnhart
Molecular and Cellular Biochemistry 1978
Platelet Antithrombins: Role of Thrombin Binding and the Release of Platelet Fibrinogen
K Watanabe, FC Chao, JL Tullis
British Journal of Haematology 1977
Thrombozytenfunktionsst�rung w�hrend der hochdosierten Substitutionstherapie bei H�mophilie A
H Gadner, E Odenwald, R Jarofke, H Riehm
Klinische Wochenschrift 1977
Binding of Thrombin to Human Platelets and its Possible Significance
P Ganguly, WJ Sonnichsen
British Journal of Haematology 1976
Binding of the products of prothrombin activation to human platelets
DM Tollefsen, CM Jackson, PW Majerus
Journal of Clinical Investigation 1975
The perturbation of thrombin binding to human platelets by anions
MA Shuman, PW Majerus
Journal of Clinical Investigation 1975
Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena
RB Colvin, HF Dvorak
Journal of Experimental Medicine 1975

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts